Skip to main content
. 2015 May 29;6(21):18374–18388. doi: 10.18632/oncotarget.4073

Figure 1. Overall survival and progression-free survival of cases grouped according to gain and amplification with MYC 1A–1B and BCL2 1C–1D in the R-CHOP-like group.

Figure 1

Abbreviations: OS: overall survival; PFS: progression-free survival.